Accessibility Menu
 

SQZ Biotechnologies

(OTC) SQZB

Current Price$0.02
Market Cap$707,800
Since IPO (2020)-100%
5 Year-100%
1 Year-40%
1 Month+0%

SQZ Biotechnologies Financials at a Glance

Market Cap

$707,800

Revenue (TTM)

$12.12M

Net Income (TTM)

$71.64M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$0.02

Volume

1,030

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.05

SQZB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SQZ Biotechnologies

Industry

Biotechnology

Employees

53

CEO

Howard Bernstein, MD, PhD

Headquarters

Watertown, MA 02472, US

SQZB Financials

Key Financial Metrics (TTM)

Gross Margin

47%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

0%

Return on Capital

-95%

Return on Assets

-74%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$707.80K

Shares Outstanding

29.49M

Volume

1.03K

Avg. Volume

1.75K

Financials (TTM)

Gross Profit

$9.79M

Operating Income

$80.68M

EBITDA

$64.14M

Operating Cash Flow

$83.55M

Capital Expenditure

$522.00K

Free Cash Flow

$84.07M

Cash & ST Invst.

$63.71M

Total Debt

$34.37M

SQZ Biotechnologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$2.23M

-470.9%

Gross Margin

0.00%

N/A

Market Cap

$707.80K

N/A

Market Cap/Employee

$13.35K

N/A

Employees

53

N/A

Net Income

$23.64M

-4.4%

EBITDA

$13.35M

+34.0%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$11.28M

-151.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$19.07M

-63.2%

Short Term Debt

$2.40M

-77.4%

Return on Assets

-74.14%

N/A

Return on Invested Capital

-94.54%

N/A

Free Cash Flow

$14.53M

+33.9%

Operating Cash Flow

$14.53M

+33.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EMMAEmmaus Life Sciences, Inc.
$0.01+0.00%
VIRXViracta Therapeutics, Inc.
$0.01+0.00%
HXBMHelix BioMedix, Inc.
$1.70+70.00%
YECOYulong Eco-Materials Limited
$0.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$16.10+0.04%
AAPLApple
$271.35+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About SQZB

What is the current price of SQZ Biotechnologies?

SQZ Biotechnologies is trading at $0.02 per share.

What is the 52-week range for SQZ Biotechnologies?

Over the past 52 weeks, SQZ Biotechnologies has traded between $0.02 and $0.05.

How much debt does SQZ Biotechnologies have?

As of the most recent reporting period, SQZ Biotechnologies reported total debt of $27.47M.

How much cash does SQZ Biotechnologies have on hand?

SQZ Biotechnologies reported $63.71M in cash and cash equivalents in its most recent financial results.

What is SQZ Biotechnologies’s dividend yield?

SQZ Biotechnologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.